Murfitt R R
Siemens Medical Electronics, Inc., Danvers, Massachusetts 01923.
J Med Eng Technol. 1990 May-Jun;14(3):111-3. doi: 10.3109/03091909009015422.
A brief history of the regulation of medical device software within the United States is presented, along with a discussion of the reasoning that the US Food and Drug Administration (FDA) presents for modifying the requirements for software regulation from those previously used for hardware devices. The current regulatory status is discussed for the two categories of medical device software, software used within medical devices and software used to produce or test medical devices. The published FDA documents which determine the current environment for the regulation of software are summarized and discussed. The two types of medical device software are related to the two areas of FDA regulation, good manufacturing practices and permission to sell medical devices. The expected direction of future medical device software regulation, and its relationship to the European Economic Community (EEC) and international markets is discussed.
本文介绍了美国医疗器械软件监管的简要历史,并讨论了美国食品药品监督管理局(FDA)提出的将软件监管要求从先前用于硬件设备的要求进行修改的理由。文中讨论了两类医疗器械软件的当前监管状况,即医疗器械中使用的软件以及用于生产或测试医疗器械的软件。总结并讨论了确定当前软件监管环境的已发布FDA文件。这两类医疗器械软件与FDA监管的两个领域相关,即良好生产规范和医疗器械销售许可。文中还讨论了未来医疗器械软件监管的预期方向及其与欧洲经济共同体(EEC)和国际市场的关系。